- Ownership
-
Zai Lab Limited Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, April 29th, 2025 | 2023 | Rafael Amado President, Head of Global Research and Development | 620,000 | 600,000 | 732,098 | 364,560 | 16,500 | 4,865,822 |
| Tuesday, April 29th, 2025 | 2024 | Rafael Amado President, Head of Global Research and Development | 636,275 | 0 | 1,305,698 | 344,593 | 17,250 | 3,645,791 |
| Tuesday, April 29th, 2025 | 2023 | Yajing Chen Chief Financial Officer | 424,445 | 0 | 467,350 | 183,617 | 16,500 | 2,014,532 |
| Tuesday, April 29th, 2025 | 2024 | Yajing Chen Chief Financial Officer | 502,500 | 0 | 920,118 | 239,616 | 17,250 | 2,625,170 |
| Tuesday, April 29th, 2025 | 2022 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 830,000 | 0 | 10,529,796 | 831,600 | 5,501 | 20,212,141 |
| Tuesday, April 29th, 2025 | 2024 | F. Ty Edmondson, Chief Legal Officer | 585,882 | 0 | 920,118 | 285,571 | 17,250 | 2,754,507 |
| Tuesday, April 29th, 2025 | 2023 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 868,500 | 0 | 1,901,226 | 815,882 | 14,440 | 12,042,285 |
| Tuesday, April 29th, 2025 | 2024 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 901,048 | 0 | 1,674,180 | 842,393 | 17,169 | 9,079,948 |
| Tuesday, April 29th, 2025 | 2023 | Josh Smiley President and Chief Operating Officer | 637,500 | 150,000 | 970,291 | 419,640 | 16,500 | 5,550,550 |
| Tuesday, April 29th, 2025 | 2024 | Josh Smiley President and Chief Operating Officer | 667,063 | 0 | 2,144,323 | 433,520 | 17,250 | 5,466,064 |
| Tuesday, April 29th, 2025 | 2022 | Rafael Amado President, Head of Global Research and Development | 2,385 | 0 | 3,868,200 | 0 | 0 | 7,501,706 |
| Monday, April 29th, 2024 | 2023 | Yajing Chen Chief Financial Officer | 424,445 | 0 | 467,350 | 183,617 | 16,500 | 2,014,532 |
| Monday, April 29th, 2024 | 2021 | Billy Cho, Former Chief Financial Officer | 466,090 | 0 | 1,602,414 | 254,880 | 0 | 4,243,676 |
| Monday, April 29th, 2024 | 2022 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 830,000 | 0 | 10,529,796 | 831,600 | 5,501 | 20,212,141 |
| Monday, April 29th, 2024 | 2021 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 774,305 | 0 | 6,726,276 | 864,000 | 4,410 | 15,315,579 |
| Monday, April 29th, 2024 | 2023 | Rafael Amado President, Head of Oncology Research and Development | 620,000 | 600,000 | 732,098 | 364,560 | 16,500 | 4,865,822 |
| Monday, April 29th, 2024 | 2023 | Harald Reinhart President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases. | 586,136 | 0 | 715,700 | 348,399 | 16,500 | 4,119,203 |
| Monday, April 29th, 2024 | 2022 | Harald Reinhart President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases. | 567,000 | 0 | 3,265,075 | 348,705 | 7,625 | 6,681,061 |
| Monday, April 29th, 2024 | 2022 | Joshua Smiley President and Chief Operating Officer | 250,000 | 250,000 | 3,639,510 | 142,101 | 5,008 | 8,296,517 |
| Monday, April 29th, 2024 | 2023 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 868,500 | 0 | 1,901,226 | 815,882 | 14,440 | 12,042,285 |
| Monday, April 29th, 2024 | 2022 | Billy Cho, Former Chief Financial Officer | 494,400 | 0 | 2,208,554 | 253,843 | 0 | 4,381,180 |
| Monday, April 29th, 2024 | 2022 | Rafael Amado President, Head of Oncology Research and Development | 2,385 | 0 | 3,868,200 | 0 | 0 | 7,501,706 |
| Monday, April 29th, 2024 | 2023 | Joshua Smiley President and Chief Operating Officer | 637,500 | 150,000 | 970,291 | 419,640 | 16,500 | 5,550,550 |
| Monday, April 29th, 2024 | 2023 | Billy Cho, Former Chief Financial Officer | 258,040 | 0 | 399,247 | 0 | 378,014 | 2,886,001 |
| Friday, April 28th, 2023 | 2022 | Joshua Smiley President and Chief Operating Officer | 250,000 | 250,000 | 3,639,510 | 142,101 | 5,008 | 8,296,517 |
| Friday, April 28th, 2023 | 2022 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 830,000 | 0 | 10,529,796 | 831,600 | 5,501 | 20,212,141 |
| Friday, April 28th, 2023 | 2021 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 774,305 | 0 | 6,726,276 | 864,000 | 4,410 | 15,315,579 |
| Friday, April 28th, 2023 | 2020 | Samantha (Ying) Du, Chief Executive Officer and Chairperson of the Board of Directors | 688,921 | 0 | 0 | 683,060 | 4,055 | 8,536,036 |
| Friday, April 28th, 2023 | 2022 | Billy Cho, Chief Financial Officer | 494,400 | 0 | 2,208,554 | 253,843 | 0 | 4,381,180 |
| Friday, April 28th, 2023 | 2021 | Billy Cho, Chief Financial Officer | 466,090 | 0 | 1,602,414 | 254,880 | 0 | 4,243,676 |
| Friday, April 28th, 2023 | 2020 | Billy Cho, Chief Financial Officer | 421,270 | 0 | 0 | 203,693 | 0 | 1,484,163 |
| Friday, April 28th, 2023 | 2021 | Alan Bart Sandler, Former President, Head of Global Development, Oncology | 540,000 | 300,000 | 3,194,047 | 345,600 | 6,708 | 6,622,039 |
| Friday, April 28th, 2023 | 2020 | Alan Bart Sandler, Former President, Head of Global Development, Oncology | 45,000 | 500,000 | 3,267,900 | 0 | 0 | 7,063,890 |
| Friday, April 28th, 2023 | 2021 | Harald Reinhart President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases. | 466,090 | 107,640 | 5,238,208 | 264,960 | 7,250 | 8,212,040 |
| Friday, April 28th, 2023 | 2022 | Alan Bart Sandler, Former President, Head of Global Development, Oncology | 463,602 | 0 | 3,265,075 | 0 | 1,108,415 | 7,329,748 |
| Friday, April 28th, 2023 | 2022 | Rafael Amado, | 2,385 | 0 | 3,868,200 | 0 | 0 | 7,501,706 |
| Friday, April 28th, 2023 | 2022 | Harald Reinhart President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases. | 567,000 | 0 | 3,265,075 | 348,705 | 7,625 | 6,681,061 |
| Monday, May 2nd, 2022 | 2020 | Samantha (Ying) Du, Chairwoman and Chief Executive Officer | 688,921 | 0 | 0 | 683,060 | 4,055 | 8,536,036 |
| Monday, May 2nd, 2022 | 2020 | Billy Cho, Chief Financial Officer | 421,270 | 0 | 0 | 203,693 | 0 | 1,484,163 |
| Monday, May 2nd, 2022 | 2021 | Billy Cho, Chief Financial Officer | 466,090 | 0 | 1,602,414 | 254,880 | 0 | 4,243,676 |
| Monday, May 2nd, 2022 | 2021 | F. Ty Edmondson, Chief Legal Officer | 521,475 | 0 | 3,043,443 | 302,573 | 4,955 | 5,629,054 |
| Monday, May 2nd, 2022 | 2020 | F. Ty Edmondson, Chief Legal Officer | 192,262 | 0 | 2,000,625 | 244,800 | 1,068 | 4,408,928 |
| Monday, May 2nd, 2022 | 2021 | Harald Reinhart President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases. | 466,090 | 107,640 | 5,238,208 | 264,960 | 7,250 | 8,212,040 |
| Monday, May 2nd, 2022 | 2021 | Alan Bart Sandler, President, Head of Global Development, Oncology | 540,000 | 300,000 | 3,194,047 | 345,600 | 6,708 | 6,622,039 |
| Monday, May 2nd, 2022 | 2019 | Billy Cho, Chief Financial Officer | 409,000 | 0 | 0 | 164,800 | 0 | 573,800 |
| Monday, May 2nd, 2022 | 2021 | Samantha (Ying) Du, Chairwoman and Chief Executive Officer | 774,305 | 0 | 6,726,276 | 864,000 | 4,410 | 15,315,579 |
| Monday, May 2nd, 2022 | 2019 | Samantha (Ying) Du, Chairwoman and Chief Executive Officer | 656,115 | 0 | 0 | 650,740 | 1,338 | 8,877,194 |
| Monday, May 2nd, 2022 | 2020 | Alan Bart Sandler, President, Head of Global Development, Oncology | 45,000 | 500,000 | 3,267,900 | 0 | 0 | 7,063,890 |
| Friday, April 30th, 2021 | 2020 | Tao Fu, President and Chief Operating Officer | 456,750 | 0 | 0 | 185,895 | 7,125 | 649,770 |
| Friday, April 30th, 2021 | 2020 | Alan Bart Sandler, President, Head of Global Development, Oncology | 45,000 | 500,000 | 3,267,900 | 0 | 0 | 7,063,890 |
| Friday, April 30th, 2021 | 2020 | Ty Edmondson, Chief Legal Officer | 192,262 | 0 | 2,000,625 | 244,800 | 1,068 | 4,408,928 |
| Friday, April 30th, 2021 | 2018 | Tao Fu, President and Chief Operating Officer | 98,437 | 0 | 4,049,375 | 65,910 | 940 | 10,489,663 |
| Friday, April 30th, 2021 | 2019 | Tao Fu, President and Chief Operating Officer | 450,000 | 300,000 | 0 | 202,500 | 7,000 | 959,500 |
| Friday, April 30th, 2021 | 2018 | Billy Cho, Chief Financial Officer | 300,000 | 300,000 | 2,184,000 | 133,699 | 0 | 8,701,699 |
| Friday, April 30th, 2021 | 2019 | Billy Cho, Chief Financial Officer | 409,000 | 0 | 0 | 164,800 | 0 | 573,800 |
| Friday, April 30th, 2021 | 2020 | Billy Cho, Chief Financial Officer | 421,270 | 0 | 0 | 203,693 | 0 | 1,484,163 |
| Friday, April 30th, 2021 | 2018 | Ying (Samantha) Du, Chairwoman and Chief Executive Officer | 638,206 | 0 | 0 | 619,752 | 0 | 6,091,458 |
| Friday, April 30th, 2021 | 2019 | Ying (Samantha) Du, Chairwoman and Chief Executive Officer | 656,115 | 0 | 0 | 650,740 | 1,338 | 8,877,194 |
| Friday, April 30th, 2021 | 2020 | Ying (Samantha) Du, Chairwoman and Chief Executive Officer | 688,921 | 0 | 0 | 683,060 | 4,055 | 8,536,036 |
